Sponsored by
VGoodiez 420EDC
  • Welcome to VaporAsylum! Please take a moment to read our RULES and introduce yourself here.
  • Need help navigating the forum? Find out how to use our features here.
  • Did you know we have lots of smilies for you to use?

Meds CBD Studies

Whisper

Whisper

Well-Known Member
This company also sells CBD. We are not endorsing the company or their products. However, there does seem to be a wealth of useful information that they've collected.

CBD FOR ACNE
CBD FOR ADHD AND ADD

CBD FOR ADDICTION & ALCOHOLISM

CBD FOR ALS

CBD FOR ALZHEIMER’S

CBD FOR ANOREXIA

CBD FOR ANTIBIOTIC RESISTANCE

CBD FOR ANXIETY


CBD FOR ARTHRITIS

CBD FOR ASTHMA

CBD FOR ATHEROSCLEROSIS

CBD FOR AUTISM

CBD FOR AUTOIMMUNE DISEASE

CBD FOR BIPOLAR

CBD FOR CANCER
CBD FOR CANCER (SPECIFIC)

CBD FOR BLADDER CANCER

CBD FOR BRAIN CANCER

CBD FOR BREAST CANCER

CBD FOR COLON CANCER

CBD FOR ENDOCRINE CANCER

CBD FOR KAPOSI SARCOMA

CBD FOR LEUKEMIA

CBD FOR LUNG CANCER

CBD FOR PROSTATE CANCER

CBD FOR SKIN CANCER

CBD FOR COLITIS AND CROHN’S

CBD FOR DEPRESSION

CBD FOR DIABETES
CBD FOR ENDOCRINE DISORDERS

CBD FOR EPILEPSY AND SEIZURES
CBD FOR FIBROMYALGIA

CBD FOR GLAUCOMA

CBD FOR HEART DISEASE

CBD FOR HIV AND AIDS

CBD FOR HUNTINGTON’S DISEASE

CBD FOR INFLAMMATION

CBD FOR IRRITABLE BOWEL SYNDROME

CBD FOR KIDNEY DISEASE

CBD FOR LIVER DISEASE

CBD FOR MIGRAINES

CBD FOR MOOD DISORDERS

CBD FOR MOTION SICKNESS

CBD FOR MULTIPLE SCLEROSIS
CBD FOR NAUSEA

CBD FOR NEURODEGENERATION


CBD FOR OBESITY

CBD FOR OBSESSIVE COMPULSIVE DISORDER


CBD FOR OSTEOPOROSIS/ BONE HEALTH

CBD FOR PAIN

CBD FOR PARKINSON’S DISEASE

CBD FOR PRION DISEASE (MAD COW)

CBD FOR PTSD (POST TRAUMATIC STRESS DISORDER)

CBD FOR RHEUMATISM

CBD FOR SCHIZOPHRENIA

CBD FOR SCLERODERMA


CBD FOR SICKLE CELL ANEMIA

CBD FOR SKIN CONDITIONS

CBD FOR SLEEP DISORDERS

CBD FOR SPINAL CORD INJURY

CBD FOR STRESS

CBD FOR STROKE

CBD FOR TRAUMATIC BRAIN INJURY (TBI)

CBD FOR WEIGHT LOSS
 
Researchers around the world are investigating CBD’s potential for treating a wide variety of conditions. Numerous studies have found that CBD exhibits analgesic and anti-inflammatory properties. These properties make it useful in the treatment of both acute pain—like muscle pulls—and chronic conditions such as arthritis.

Mod note: Edited to remove link to CBD supply store.
 
Last edited by a moderator:
CBD AS A STEROID SPARING TREATMENT
Could cannabidiol be a breakthrough therapy to replace or lessen the use of steroids?

Most of us have been prescribed steroids by a doctor at some point in our lives. They are often the go-to choice to treat sudden bouts of inflammation, allergies or when a physician is simply stuck on what to give a patient. Their immediate effects may seem miraculous. (Oh wow suddenly I have so much energy, my appetite’s back, and my mysterious rash disappeared.) But long-term steroid use comes with a host of side effects.

Enter cannabidiol (CBD), an unexpected contender for a novel steroid sparing treatment of the future.

THE WORLD GOES WILD ABOUT STEROIDS
After their first recorded use for rheumatoid arthritis in 1948,1 corticosteroids (steroids) quickly became the main immunosuppressive treatment for patients with systemic inflammatory conditions or to prevent rejection after organ transplants. So transformative were their effects that Dr. Philip Hench, Edward Calvin Kendall and Tadeus Reichstein were awarded the 1950 Nobel Prize for Physiology or Medicine for their discovery of the hormone cortisone and its clinical application in rheumatoid arthritis.

A crowd pleaser with patients, steroids were often overprescribed by doctors. Before long a link between steroids and increased morbidity in patients became apparent, and researchers began to find ‘steroid sparing’ immunosuppressant drugs. That said, to this day steroids continue to be prescribed (my dog even had a short dose for a mystery itch in her right ear), although most physicians limit this to short periods of time.

There’s no get-out-of jail-free pass with steroids, which can cause unpleasant and sometimes dangerous side effects.

WHAT ARE STEROIDS?
It was Dr. Philip Hench who first posited that steroids – hormones produced in the adrenal glands – alleviate pain associated with rheumatoid arthritis. With the development of corticosteroid drugs like cortisone, hydrocortisone, and prednisone that mimic our endogenous steroids, a new effective way was discovered to reduce inflammation in the body.

But there’s no ‘get out of jail free’ pass with steroids, as their use is often accompanied by unpleasant and sometimes dangerous side effects.2 These include glaucoma, cataracts, fluid retention, high blood pressure, mood swings, weight gain, diabetes, increased risk of infections, osteoporosis, suppressed adrenal gland function, thin skin, and slower wound healing.

Consequently, doctors only prescribe steroids as a short-term solution, a measure considered relatively safe. Hence, steroids are commonly given to patients with sudden flare ups in autoimmune conditions like Crohn’s disease when short, sharp immunosuppression is required.

However, it’s not just the steroid side effects that can be problematic for patients. Coming off steroids, particularly when a patient has been prescribed short term high doses or lower doses over a longer period of time can result in ‘steroid withdrawal syndrome.’3 This happens when the body has become reliant on the ‘pharmaceutical’ steroids, leading its own endogenous production through the hypothalamic-pituitary-adrenal (HPA) axis to weaken and flatline.

As such, patients should not suddenly stop taking steroids. Instead the dose has to be gradually tapered downwards, otherwise symptoms such as weakness, fatigue, decreased appetite, weight loss, nausea, vomiting, diarrhea, abdominal pain and headaches can occur.

STEROID WITHDRAWAL
Eve Roginska, a London based tattoo artist, became dangerously ill with a sudden inflammatory brain condition and was initially given high doses of intravenous steroids. She had been taking steroids for the last two years – but stopping was difficult.

Over time Eve was able to gradually lower the dose. However, whenever she tried to drop below 20mg of steroids a day, she experienced debilitating withdrawal symptoms similar to coming off drugs.

“I was having terrible migraines, and my painkillers weren’t working and sometimes this lasted all day,” recalls Eve. “I had terrible trouble sleeping. Even sleeping tablets didn’t work for me anymore. Then the whole day my body would feel exhausted. A lot of fatigue and a lot of muscle pain. I had brain fog continuously and kept forgetting things.”

Eve was familiar with CBD oil, so she decided to see if it could ease her withdrawal symptoms. This may have been little more than an educated hunch, but it was one that paid off.

“Three days after starting with CBD, my migraines just went away. After a week or two taking it, I felt like a normal person,” she says.

Eve has now reduced her steroids to 1mg a day and hopes to quit them completely by the summer. She’s has no doubt about the difference CBD has made to her recovery.

“I would probably have to be on steroids for the rest of my life if it wasn’t for this oil,” she acknowledges. “It’s returned my life back.”

STEROID SPARING DRUGS
Unbeknownst to Eve, around the same time she was using CBD to wean herself off steroids, some Israeli scientists were actually researching CBD as a steroid sparing treatment.

Steroid sparing agents4 are drugs that either allow for a reduction in the amount of steroids taken or can even be the first-line choice for suppressing the immune system. Examples of steroid sparing drugs include cyclophosphamide, chlorambucil, methotrexate, mycophenolate mofetil, azathioprine, cyclosporine, tacrolimus, and sirolimus. That’s not to say that taking steroid sparing agents is any walk in the park. Many of them are classed as chemotherapy drugs and come with their own unpleasant side effects.

“I would probably have to be on steroids for the rest of my life if not for CBD oil.”

Eve herself began taking methotrexate a year into her illness and for the first few months experienced diarrhoea, hair loss, nausea, nail and skin problems, fatigue, abdominal bloating, disruption to her menstrual cycle, urinary tract infections, and mouth ulcers. Long term use of immunosuppressants has also been linked to a greater risk of developing cancer in later life.5

Little wonder that the hunt is on for less harmful immunosuppressive, steroid sparing agents – and CBD could be near the front of the pack.

Scientists know that CBD has an overall anti-inflammatory/immunosuppressive effect by reducing the production of pro-inflammatory cytokines6 and inhibiting T-cell function.7 This probably explains why many patients with autoimmune conditions such as Crohn’s disease and rheumatoid arthritis report an improvement in symptoms when taking CBD oil.

CLINICAL TRIALS FOR CBD
Steroid sparing drugs are often first developed to prevent rejection after transplants, and this holds true for CBD, as well. In a small phase IIclinical trial,8 Israeli researchers wanted to see whether CBD could prevent graft-versus-host disease (GVHD) in steroid-resistant patients. Often a fatal condition, GVHD occurs after a bone marrow transplant when the donated bone marrow views the recipient’s body as foreign and attacks it.

Nine out of the ten subjects responded to the CBD treatment, with most of them achieving a ‘complete response.’ While the results have not been published in a peer reviewed journal, the team behind the study maintain CBD “either enhanced the therapeutic effect of steroids or reduced steroid dosage while maintaining or improving the steroid’s therapeutic effect. Even more surprisingly, patients resistant to steroid treatment also presented significant improvement under the CBD treatment.”

Buoyed by these encouraging results, they have begun recruiting for phase II clinical trials for CBD as a steroid sparing treatment in Crohn’s disease9 and autoimmune hepatitis.10 In both trials, patients will gradually shift from their current treatment (steroids or immunosuppressants) to just taking 300mg of synthetic CBD daily.

Of course, an early stage phase II study does not mean that CBD, synthetic or otherwise, is a proven and safe alternative to steroids or other immunosuppressant drugs. Furthermore, any decision to reduce or come off steroids, should always be carried out in conjunction with your physician. But it does point towards a possible future when CBD could be a more benign but equally effective alternative to steroids after transplants and in the treatment of autoimmune diseases.

SOURCES
  1. Amy K Saenger. Discovery of the Wonder Drug: From Cows to Cortisone. Clinical Chemistry, Volume 56, Issue 8, 1 August 2010, Pages 1349–1350.
  2. Muhammad Yasir et al. Corticosteroid Adverse Effects. StatPearls Publishing; 2020 Jan.
  3. Leon Margolin et al. The Steroid Withdrawal Syndrome: A Review of the Implications, Etiology, and Treatments. Journal of Pain and Symptom Management. February 2007. Volume 33, Issue 2, Pages 224–228
  4. J Kruh et al. Corticosteroid-sparing agents: conventional systemic immunosuppressants. Developments in Ophthalmology. 2012;51:29-46.
  5. Martin P. Gallagher et al. Long-Term Cancer Risk of Immunosuppressive Regimens after Kidney Transplantation. J Am Soc Nephrol. 2010 May; 21(5): 852–858.
  6. Francieli Vuolo et al. Evaluation of Serum Cytokines Levels and the Role of Cannabidiol Treatment in Animal Model of Asthma. Mediators of Inflammation. 2015
  7. L Barbara et al. The Profile of Immune Modulation by Cannabidiol (CBD) Involves Deregulation of Nuclear Factor of Activated T Cells (NFAT). Biochem Pharmacol. 2008 Sep 15; 76(6): 726–737.
  8. Shakera Halim. Are steroids truly a necessary evil? – a groundbreaking CBD-based alternative. Health Europa. 16th September 2019
  9. ClinicalTrials.gov. A Phase 2a Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol as a Steroid-sparing Therapy in Steroid-dependent Crohn’s Disease Patients
  10. ClinicalTrials.gov. A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis
 
www.marijuanamoment.net

FDA Explains Effects Of CBD And Marijuana Compounds Based On Sex And Gender Differences

The Food and Drug Administration (FDA) announced on Tuesday that it will be hosting a public meeting in November to discuss gender and sex differences in the effects of CBD and other cannabinoids. In a notice set to be published in the Federal Register on Wednesday, FDA’s Office of Women’s...
www.marijuanamoment.net www.marijuanamoment.net


FDA Explains Effects Of CBD And Marijuana Compounds Based On Sex And Gender Differences

ABOUT MARIJUANA MOMENT

POLITICS
FDA Explains Effects Of CBD And Marijuana Compounds Based On Sex And Gender Differences
3b71d81faa493372a683c777756df1f4

Published
8 hours ago
on
September 22, 2020
By
Kyle Jaeger
sam-doucette-1183203-unsplash.jpg

  • The Food and Drug Administration (FDA) announced on Tuesday that it will be hosting a public meeting in November to discuss gender and sex differences in the effects of CBD and other cannabinoids.
In a notice set to be published in the Federal Register on Wednesday, FDA’s Office of Women’s Health announced the event, emphasizing that as interest in CBD and other derivatives of marijuana and hemp continues to grow, there’s a need to explore the science of these cannabinoids in the context of gender and sex. That’s particularly true when it comes to cannabis use among pregnant women, the agency said.

“Researchers, educators, clinicians, and patients may benefit from attending this multidisciplinary scientific conference on CBD and other cannabinoids,” FDA said. “Presentations will address patient and healthcare provider perspectives on CBD and other cannabinoid use, sex differences in the effects of CBD and other cannabinoids, use of CBD and other cannabinoids in pregnancy, and government agency perspectives on CBD research and evaluation.”

“FDA recognizes the significant public interest in cannabis
 

​

Dumping CBD Oil On Strawberries Extends Their Shelf Life And Stops Mold Growth, New Study Finds​


CBD is marketed to help with a dizzying array of human wellness issues—but now you can add fruit preservation to that list, according to a recent study.

Yes, the non-intoxicating cannabinoid apparently helps strawberries stay fresh, researchers at the University of South Florida found.

The study—set to be published in the journal Postharvest Biology and Technology—tested the antimicrobial effects of CBD by dousing strawberries in CBD oil after they’d been harvested. Researchers wanted to know if doing so would “reduce microbial growth and extend the shelf life.”

“Treating strawberries with CBD oil lengthens shelf life and reduces microbial load.”
Click to expand...
“Strawberries were evaluated for visual quality and microbial load before and during storage,” the paper’s abstract states. “Results from this study showed that CBD oil was effective at maintaining the visual appearance of strawberries…compared to the fruit that was not treated.”

There was also a significant reduction in the microbial load that the fruits carried if they were treated with CBD, versus those that were not. That resulted in less mold and yeast production, too.

“CBD oil inhibited yeast and mold growth on strawberries. Strawberries treated with CBD oil had better overall quality compared to non-[treated] fruit.”
Click to expand...
While the study focused on strawberries, the findings indicate that “CBD oil has promising potential as an antimicrobial treatment to fresh produce” in general, the authors concluded.

To achieve the extended freshness, researchers stored the cannabinoid-treated fruit at at 1 degree Celsius for 8 days and 10 degrees Celsius for to 8 days. The results show that “CBD oil has the potential to be used by consumers at home as an effective antimicrobial treatment and to extend strawberry shelf life,” they wrote.

In other unexpected cannabidiol benefits, separate research published earlier this year highlighted the promise of CBD-infused mouthwash.

The new strawberry study states that because of the current lack of federal regulations for the cannabis compound “there are still many uncertainties surrounding the use of CBD as a food additive and the science and benefits behind using CBD in food formulations.”

That could change as the Food and Drug Administration (FDA) continues to finalize rules for the compound.

The agency was mandated under appropriations legislation enacted late last year to provide an update on its regulatory approach to CBD, and it did so in March. The update stated that “FDA is currently evaluating issuance of a risk-based enforcement policy that would provide greater transparency and clarity regarding factors FDA intends to take into account in prioritizing enforcement decisions.”

FDA has been using enforcement discretion for CBD in the years since hemp became legal and has continued to issue warnings to cannabis businesses in certain cases—such as instances in which companies claimed CBD could treat or cure coronavirus—and provide public notices about recalls.

In July, FDA also submitted a report to Congress on the state of the CBD marketplace, and the document outlines studies the agency has performed on the contents and quality of cannabis-derived products that it has tested over the past six years.

Also that month, a congressional spending bill for FDA was released that includes a provision providing “funding to develop a framework for regulating CBD products.”

The agency is also actively looking to award a contract to help study CBD as it develops regulations for products containing the non-intoxicating cannabinoid.
 
Come on.... we all know cannabis preserves right...
All people i know that use cannabis are very well preserved....
 

CBD Could Inhibit Nicotine Metabolism, According to New Study​

A new study found that CBD slows down nicotine enzyme metabolism, which could potentially help nicotine-addicted people smoke less.

A recent study conducted by Washington State University (WSU) examined how CBD could potentially help curb cigarette smoking. It was originally published in the journal Chemical Research in Toxicology on Jan. 10, but the university shared a press release about its findings on Feb. 16.

The study, called “Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD),” used human liver tissue and cell samples, and found that CBD “inhibited a key enzyme for nicotine metabolism.” Slowing metabolism of nicotine’s key enzyme could help smokers wait before they need to inhale more, according to an WSU press release.

“The whole mission is to decrease harm from smoking, which is not from the nicotine per se, but all the carcinogens and other chemicals that are in tobacco smoke,” said Philip Lazarus, Senior Author and WSU Professor of Pharmaceutical Sciences. “If we can minimize that harm, it would be a great thing for human health.”

The study found that CBD slowed many nicotine enzymes, including the enzyme CYP2A6 which metabolizes more than 70% of nicotine in smokers. The researchers found that CBD inhibited the activity of CYP2A6 by 50%. “In other words, it appears that you don’t need much CBD to see the effect,” Lazarus said.

Lazarus and his team are currently working on a clinical study to learn more about how CBD can affect nicotine in smokers by measuring a participant’s nicotine levels in their blood between a six-to-eight-hour period. Eventually, the team hopes to expand their research efforts to examine CBD and nicotine addiction on a larger scale as well. The most recent study was conducted with the help of a grant from the National Institute of Health.

In August 2021, researchers at Mydecine Innovations Group signed a five-year research agreement with Johns Hopkins University to analyze how psychedelic formulations could help smokers overcome smoking addiction.

However, many cigarette smokers are just moving to cannabis consumption instead. The annual Gallup Consumption Survey published in August last year found that only 11% of Americans identified as cigarette smokers, and 16% identified as cannabis consumers. The percentage of cigarette smokers is at it’s lowest percentage yet since Gallup began asking the questions in the 1940s. In 1947, when asked if participants have smoked cigarettes in the past week, 41% said yes. In 1949 the percentage rose to 44%, and reached a height of 45% in 1954.

“Smoking cigarettes is clearly on the decline and is most likely to become even more of a rarity in the years ahead,” said Gallup Author Frank Newport about the newest results. “This reflects both public awareness of its negative effects and continuing government efforts at all levels to curtail its use. Smoking remains legal in general but is prohibited in many public places, offices, modes of transportation and in private places across the U.S. Each pack of cigarettes carries draconian warning messages about their harmful effects.”

An Australia-based study found similar results with residents preferring cannabis to smoking tobacco. The Australian Institute of Health and Welfare analyzed data from 2019in its newest analysis, and found that 20% of respondents support regular cannabis use, and only 15% support tobacco use.

Legislators in some states such as California are introducing bills to ban tobacco completely. Assembly Bill 935, which was recently introduced by Assemblymembers Damon Connolly and Evan Low, would ban tobacco products for anyone born after Jan. 1, 2007. “Preventing the next generation of Californians from becoming addicted to smoking should be a priority for anyone who cares about public health and the well-being of our children,” Connolly said.
 
momofthegoons said:

CBD Could Inhibit Nicotine Metabolism, According to New Study​

A new study found that CBD slows down nicotine enzyme metabolism, which could potentially help nicotine-addicted people smoke less.

A recent study conducted by Washington State University (WSU) examined how CBD could potentially help curb cigarette smoking. It was originally published in the journal Chemical Research in Toxicology on Jan. 10, but the university shared a press release about its findings on Feb. 16.

The study, called “Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD),” used human liver tissue and cell samples, and found that CBD “inhibited a key enzyme for nicotine metabolism.” Slowing metabolism of nicotine’s key enzyme could help smokers wait before they need to inhale more, according to an WSU press release.

“The whole mission is to decrease harm from smoking, which is not from the nicotine per se, but all the carcinogens and other chemicals that are in tobacco smoke,” said Philip Lazarus, Senior Author and WSU Professor of Pharmaceutical Sciences. “If we can minimize that harm, it would be a great thing for human health.”

The study found that CBD slowed many nicotine enzymes, including the enzyme CYP2A6 which metabolizes more than 70% of nicotine in smokers. The researchers found that CBD inhibited the activity of CYP2A6 by 50%. “In other words, it appears that you don’t need much CBD to see the effect,” Lazarus said.

Lazarus and his team are currently working on a clinical study to learn more about how CBD can affect nicotine in smokers by measuring a participant’s nicotine levels in their blood between a six-to-eight-hour period. Eventually, the team hopes to expand their research efforts to examine CBD and nicotine addiction on a larger scale as well. The most recent study was conducted with the help of a grant from the National Institute of Health.

In August 2021, researchers at Mydecine Innovations Group signed a five-year research agreement with Johns Hopkins University to analyze how psychedelic formulations could help smokers overcome smoking addiction.

However, many cigarette smokers are just moving to cannabis consumption instead. The annual Gallup Consumption Survey published in August last year found that only 11% of Americans identified as cigarette smokers, and 16% identified as cannabis consumers. The percentage of cigarette smokers is at it’s lowest percentage yet since Gallup began asking the questions in the 1940s. In 1947, when asked if participants have smoked cigarettes in the past week, 41% said yes. In 1949 the percentage rose to 44%, and reached a height of 45% in 1954.

“Smoking cigarettes is clearly on the decline and is most likely to become even more of a rarity in the years ahead,” said Gallup Author Frank Newport about the newest results. “This reflects both public awareness of its negative effects and continuing government efforts at all levels to curtail its use. Smoking remains legal in general but is prohibited in many public places, offices, modes of transportation and in private places across the U.S. Each pack of cigarettes carries draconian warning messages about their harmful effects.”

An Australia-based study found similar results with residents preferring cannabis to smoking tobacco. The Australian Institute of Health and Welfare analyzed data from 2019in its newest analysis, and found that 20% of respondents support regular cannabis use, and only 15% support tobacco use.

Legislators in some states such as California are introducing bills to ban tobacco completely. Assembly Bill 935, which was recently introduced by Assemblymembers Damon Connolly and Evan Low, would ban tobacco products for anyone born after Jan. 1, 2007. “Preventing the next generation of Californians from becoming addicted to smoking should be a priority for anyone who cares about public health and the well-being of our children,” Connolly said.
Click to expand...


Good for green outs too!!!!
 
You must log in or register to reply here.

Sponsored by
VGoodiez 420EDC
Back
Top